Castle Biosciences Inc (CSTL) — 8-K Filings
All 8-K filings from Castle Biosciences Inc. Browse 6 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (6)
-
Castle Biosciences Amends Articles of Incorporation
— Aug 8, 2025 Risk: low
Castle Biosciences, Inc. filed an 8-K on August 8, 2025, reporting an amendment to its Articles of Incorporation, effective August 5, 2025. This filing indicate -
Castle Biosciences Files 8-K on Security Holder Rights & Corporate Actions
— May 23, 2025 Risk: medium
On May 22, 2025, Castle Biosciences, Inc. filed an 8-K report detailing several key events. These include material modifications to the rights of security holde -
Castle Biosciences Files 8-K on Financials
— Jan 13, 2025 Risk: low
Castle Biosciences, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition as of January 12, 2025. The filing als -
Castle Biosciences Reports on Shareholder Vote Outcome
— May 24, 2024 Risk: low
Castle Biosciences, Inc. filed an 8-K on May 24, 2024, reporting on a matter submitted to a vote of its security holders on May 23, 2024. The filing details the -
Castle Biosciences Appoints New Chief Medical Officer
— Mar 27, 2024 Risk: medium
Castle Biosciences, Inc. announced on March 26, 2024, the departure of its Chief Medical Officer, Dr. Derek J. Maathuis. The company also announced the appointm -
Castle Biosciences Files 8-K on Financial Condition & Operations
— Jan 8, 2024
Castle Biosciences, Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 7, 2024. This filing indicates that the company is providi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX